Fabrizio Nelli (F Nelli)

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Venues

Cancers

Clinical and experimental medicine

Current oncology (Toronto, Ont.)

Cancer immunology, immunotherapy : CII

This page only lists publications with an associated author ORCID identifier.

Publications

Fabrizio Nelli, Agnese Fabbri, Antonella Virtuoso, Diana Giannarelli, Julio Rodrigo Giron Berrios, Eleonora Marrucci, Cristina Fiore, Enzo Maria Ruggeri
Early Changes in LIPI Score Predict Immune-Related Adverse Events: A Propensity Score Matched Analysis in Advanced Non-Small Cell Lung Cancer Patients on Immune Checkpoint Blockade. Cancers 16 (2) (2024)
Fabrizio Nelli, Agnese Fabbri, Antonella Virtuoso, Diana Giannarelli, Julio Rodrigo Giron Berrios, Eleonora Marrucci, Cristina Fiore, Enzo Maria Ruggeri
Early Changes in LIPI Score Predict Immune-Related Adverse Events: A Propensity Score Matched Analysis in Advanced Non-Small Cell Lung Cancer Patients on Immune Checkpoint Blockade. Cancers 16 (2) (2024)
Fabrizio Nelli, Agnese Fabbri, Antonella Virtuoso, Diana Giannarelli, Eleonora Marrucci, Cristina Fiore, Julio Rodrigo Giron Berrios, Marta Schirripa, Carlo Signorelli, Mario Giovanni Chilelli, Francesca Primi, Valentina Panichi, Luciano Caterini, Stefania Farinelli, Maria Assunta Silvestri, Enzo Maria Ruggeri
Herpes zoster after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: a prospective study. Clinical and experimental medicine 24 (1) (2024)
Fabrizio Nelli, Agnese Fabbri, Antonella Virtuoso, Diana Giannarelli, Eleonora Marrucci, Cristina Fiore, Julio Rodrigo Giron Berrios, Marta Schirripa, Carlo Signorelli, Mario Giovanni Chilelli, Francesca Primi, Valentina Panichi, Luciano Caterini, Stefania Farinelli, Maria Assunta Silvestri, Enzo Maria Ruggeri
Herpes zoster after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: a prospective study. Clinical and experimental medicine 24 (1) (2024)
Fabrizio Nelli, Agnese Fabbri, Antonella Virtuoso, Diana Giannarelli, Eleonora Marrucci, Cristina Fiore, Julio Rodrigo Giron Berrios, Marta Schirripa, Carlo Signorelli, Mario Giovanni Chilelli, Francesca Primi, Valentina Panichi, Luciano Caterini, Stefania Farinelli, Maria Assunta Silvestri, Enzo Maria Ruggeri
Herpes zoster after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: a prospective study. Clinical and experimental medicine 24 (1) (2024)
Fabrizio Nelli, Diana Giannarelli, Agnese Fabbri, Antonella Virtuoso, Julio Rodrigo Giron Berrios, Eleonora Marrucci, Cristina Fiore, Marta Schirripa, Carlo Signorelli, Mario Giovanni Chilelli, Francesca Primi, Valentina Panichi, Giuseppe Topini, Maria Assunta Silvestri, Enzo Maria Ruggeri
Immune-related adverse events and disease outcomes after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients receiving immune checkpoint inhibitors. Cancer immunology, immunotherapy : CII (2023)
Fabrizio Nelli, Carlo Signorelli, Agnese Fabbri, Diana Giannarelli, Antonella Virtuoso, Julio Rodrigo Giron Berrios, Eleonora Marrucci, Cristina Fiore, Marta Schirripa, Mario Giovanni Chilelli, Francesca Primi, Valentina Panichi, Giuseppe Topini, Maria Assunta Silvestri, Enzo Maria Ruggeri
Changes in Peripheral Immune Cells after the Third Dose of SARS-CoV-2 mRNA-BNT162b2 Vaccine and Disease Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Prospective Analysis of the Vax-on-Third-Profile Study. Cancers 15 (14) (2023)
Fabrizio Nelli, Agnese Fabbri, Antonella Virtuoso, Diana Giannarelli, Julio Rodrigo Giron Berrios, Eleonora Marrucci, Cristina Fiore, Marta Schirripa, Carlo Signorelli, Mario Giovanni Chilelli, Francesca Primi, Gloria Pessina, Federica Natoni, Maria Assunta Silvestri, Enzo Maria Ruggeri
Effects of Antibody Response after Booster Vaccination on SARS-CoV-2 Breakthrough Infections and Disease Outcomes in Advanced Cancer Patients: A Prospective Analysis of the Vax-on-Third Study. Current oncology (Toronto, Ont.) 30 (5) (2023)
Fabrizio Nelli, Antonella Virtuoso, Diana Giannarelli, Agnese Fabbri, Julio Rodrigo Giron Berrios, Eleonora Marrucci, Cristina Fiore, Enzo Maria Ruggeri
Effects of Acetaminophen Exposure on Outcomes of Patients Receiving Immune Checkpoint Inhibitors for Advanced Non-Small-Cell Lung Cancer: A Propensity Score-Matched Analysis. Current oncology (Toronto, Ont.) 30 (9) (2023)
Fabrizio Nelli, A Virtuoso, J R Giron Berrios, D Giannarelli, A Fabbri, E Marrucci, E M Ruggeri
Impact of previous corticosteroid exposure on outcomes of patients receiving immune checkpoint inhibitors for advanced non-small cell lung cancer: a retrospective observational study. Cancer chemotherapy and pharmacology 89 (4) (2022)
Fabrizio Nelli, Valentina Panichi, Agnese Fabbri, Federica Natoni, Diana Giannarelli, Giuseppe Topini, Antonella Virtuoso, Julio Rodrigo Giron Berrios, Eleonora Marrucci, Gloria Pessina, Maria Assunta Silvestri, Enzo Maria Ruggeri
Dynamic Changes of Peripheral NK Cells Predict Outcome in Patients with PD-L1 Positive Non-small-cell Lung Cancer Undergoing Immune Checkpoint Inhibitors as Second-line Therapy. Cancer investigation 40 (8) (2022)

Fabrizio Nelli.css-eqlu8i{font-size:small;padding-left:4px;} (F Nelli)

Publication Activity (10 Years)

Top Topics

Top Venues

Fabrizio Nelli (F Nelli)